You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tanespimycin

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Thyroid Cancer, Stage IV Follicular Thyroid Cancer, Stage IV Papillary Thyroid Cancer Trial in Rochester

Completed
Has Results
  • Recurrent Thyroid Cancer
  • +3 more
  • tanespimycin
  • Rochester, Minnesota
    Mayo Clinic
Dec 28, 2016

Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer Trial in Detroit (tanespimycin, laboratory biomarker

Terminated
Has Results
  • Recurrent Breast Cancer
  • +3 more
  • tanespimycin
  • laboratory biomarker analysis
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Nov 18, 2016

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Rochester (tanespimycin, laboratory

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +2 more
  • tanespimycin
  • laboratory biomarker analysis
  • Rochester, Minnesota
    Mayo Clinic
Mar 20, 2017

Multiple Myeloma Trial in United States (tanespimycin, Bortezomib)

Completed
  • Multiple Myeloma
  • Berkeley, California
  • +10 more
Nov 6, 2015

Solid Tumors, Breast Cancer Trial in Scottsdale, Tucson, New York (Tanespimycin)

Completed
  • Solid Tumors
  • Breast Cancer
  • Tanespimycin
  • Scottsdale, Arizona
  • +2 more
Oct 12, 2015

Advanced Malignancies Trial in Boston (Tanespimycin)

Completed
  • Advanced Malignancies
  • Tanespimycin
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Sep 23, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (gemcitabine HCl,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • tanespimycin
  • Rochester, Minnesota
    Mayo Clinic
Jul 23, 2014

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage III Ovarian Epithelial Cancer Trial in Rochester

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • +3 more
  • gemcitabine hydrochloride
  • tanespimycin
  • Rochester, Minnesota
    Mayo Clinic
May 2, 2014

Recurrent Prostate Cancer, Stage IV Prostate Cancer, Solid Tumor Trial in New York (tanespimycin, docetaxel)

Completed
  • Recurrent Prostate Cancer
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 16, 2014

Solid Tumor Trial in Detroit (drug, other, procedure)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • sorafenib tosylate
  • +4 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Jun 16, 2014

Solid Tumor Trial in Rochester (gemcitabine HCl, tanespimycin, cisplatin)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • gemcitabine hydrochloride
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jun 3, 2013

MALT, Nodal Marginal Zone B-cell Lymphoma, Non-Hodgkin Lymphoma Trial in Omaha (tanespimycin)

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +27 more
  • tanespimycin
  • Omaha, Nebraska
    University of Nebraska Medical Center
Dec 13, 2013

Recurrent Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in New York (tanespimycin, laboratory biomarker analysis)

Terminated
  • Recurrent Melanoma
  • +2 more
  • tanespimycin
  • laboratory biomarker analysis
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 9, 2013

Solid Tumor Trial in London (tanespimycin)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • tanespimycin
  • London, England, United Kingdom
    Royal Marsden NHS Foundation Trust - London
Jun 25, 2013

Kidney Cancer Trial in New York (tanespimycin)

Completed
  • Kidney Cancer
  • tanespimycin
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 21, 2013

Leukemia Trial in Los Angeles (tanespimycin)

Completed
  • Leukemia
  • tanespimycin
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 9, 2013

Melanoma (Skin) Trial in Cambridge, Sutton (tanespimycin)

Completed
  • Melanoma (Skin)
  • tanespimycin
  • Cambridge, England, United Kingdom
  • +1 more
Jun 25, 2013

Solid Tumor Trial in New York (tanespimycin, irinotecan HCl)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • tanespimycin
  • irinotecan hydrochloride
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 3, 2013

Bladder Cancer, Breast Cancer, Colorectal Cancer Trial in Los Angeles, New York (tanespimycin)

Completed
  • Bladder Cancer
  • +11 more
  • tanespimycin
  • Los Angeles, California
  • +1 more
Jun 20, 2013

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +2 more
  • tanespimycin
  • rituximab
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Leukemia Trial in Detroit (imatinib mesylate, tanespimycin)

Completed
  • Leukemia
  • imatinib mesylate
  • tanespimycin
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 3, 2013

Solid Tumor Trial in Philadelphia (tanespimycin, paclitaxel, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • tanespimycin
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Medical Center
Jan 24, 2013

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Columbus

Terminated
  • Adult Acute Basophilic Leukemia
  • +34 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Terminated
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +59 more
  • tanespimycin
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
May 15, 2013

AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma Trial in Pittsburgh

Completed
  • AIDS-related Peripheral/Systemic Lymphoma
  • +52 more
  • tanespimycin
  • pharmacological study
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 6, 2013